Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring

Reproductive Sciences

Volumn 17, Issue 2, 2010, Pages 168-176

  Gezmish, Oksan ^a   Tare, Marianne ^a   Parkington, Helena C ^a   Morley, Ruth ^b   Porrello, Enzo R ^b   Bubb, Kristen J ^a   Black, Mary Jane ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiomegaly; Heart; Maternal vitamin D deficiency; Rat offspring

Indexed keywords

VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL GROWTH; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CELL SIZE; CONCEPTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIET; FEMALE; HEART DEVELOPMENT; HEART FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; LACTATION; MALE; NONHUMAN; POSTNATAL GROWTH; PREGNANCY; PRIORITY JOURNAL; PROGENY; RAT; SPRAGUE DAWLEY RAT; VITAMIN D DEFICIENCY;

ANIMAL FEED; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CALCIFEDIOL; CALCIUM; CARDIOMEGALY; CELL COUNT; CELL DIVISION; CELL NUCLEUS; FEMALE; MALE; MYOCYTES, CARDIAC; ORGAN SIZE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 76249084038     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719109349536     Document Type: Article

References (37)

1. Holick MF Vitamin D deficiency. N Engl J Med. 2007 ; 357 (3). 266-281.
2. Holick MF Vitamin D.: A millennium perspective. J Cell Biochem. 2003 ; 88 (2). 296-307.
3. Holick MF Vitamin D.: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002 ; 9 (1). 87-98.
4. Grover SR, Morley R. Vitamin D deficiency in veiled or dark-skinned pregnant women. Med J Aust. 2001 ; 175 (5). 251-252.
5. Nesby-O-™Dell S., Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002 ; 76 (1). 187-192.
6. Maiya S., Sullivan I., Allgrove J., et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart. 2008 ; 94 (5). 581-584.
7. Holick MF, Chen TC Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 ; 87 (4). 1080S - 1086S.
8. Cannell JJ, Hollis BW Use of vitamin D in clinical practice. Altern Med Rev. 2008 ; 13 (1). 6-20.
9. Lee JH, O-™Keefe JH, Bell D., Hensrud DD, Holick MF Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008 ; 52 (24). 1949-1956.
10. Kovacs CS Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr. 2008 ; 88 (2). 520S - 528S.
11. Bassir M., Laborie S., Lapillonne A., Claris O., Chappuis MC, Salle BL. Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr. 2001 ; 90 (5). 577-579.
12. Tare M., Parkington HC, Morley R. Vitamin D in pregnancy and offspring health. Adv Exp Med Biol. 2006 ; 573: 195-203.
13. Kosecik M., Ertas T. Dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Pediat Int. 2007 ; 49 (3). 397-399.
14. Uysal S., Kalayci AG, Baysal K. Cardiac functions in children with vitamin D deficiency rickets. Pediatr Cardiol. 1999 ; 20 (4). 283-286.
15. Nagpal S., Na S., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005 ; 26 (5). 662-687.
16. Somjen D., Earon Y., Harell S., et al. Developmental changes in responsiveness to vitamin D metabolites. J Steroid Biochem. 1987 ; 27 (4-6). 807-813.
17. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience. 2003 ; 118 (3). 641-653.
18. Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A., Simpson RU 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol. 2007 ; 103 (3-5). 533-537.
19. O-™Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol. 1997 ; 272 (4 pt 2). H1751 - H1758.
20. Halloran BP, Barthell EN, DeLuca HF. Vitamin D metabolism during pregnancy and lactation in the rat. Proc Natl Acad Sci U S A. 1979 ; 76 (11). 5549-5553.
21. Li F., Wang X., Capasso JM, Gardes AM Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol. 1996 ; 28 (8). 1737-1746.
22. Weishaar RE, Kim SN, Saunders DE, Simpson RU Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol. 1990 ; 258 (1 pt 1). E134 - E142.
23. Olgun H., Ceviz N., Ozkan B. A case of dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Turk J Pediatr. 2003 ; 45 (2). 152-154. (Pubitemid 36850061)
24. Maka N., Makrakis J., Parkington HC, Tare M., Morley R., Black MJ. Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Pediatc Nephrol. 2008 ; 23 (1). 55-61.
25. Zimanyi MA, Bertram JF, Black MJ Does a nephron deficit in rats predispose to salt-sensitive hypertension ? Kidney Blood Press Res. 2004 ; 27 (4). 239-247.
26. Corstius HB, Zimanyi MA, Maka N., et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res. 2005 ; 57 (6). 796-800.
27. Gundersen HJ, Bendtsen TF, Korbo L., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988 ; 96 (5). 379-394.
28. Myers M., Britt KL, Wreford NG, Ebling FJ, Kerr JB Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004 ; 127 (5). 569-580.
29. Bubb KJ, Cock ML, Black MJ, et al. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J Physiol. 2007 ; 578 (pt 1). 871-881.
30. Feldman D., Skowronski RJ, Peehl DM Vitamin D and prostate cancer. Adv Exp Med Biol. 1995 ; 374: 53-63.
31. Miyaura C., Abe E., Kuribayashi T., et al. 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 1981 ; 102 (3). 937-943. (Pubitemid 12213816)
32. Carlton-Conway D., Tulloh R., Wood L., Kanabar D. Vitamin D deficiency and cardiac failure in infancy. J R Soc Med. 2004 ; 97 (5). 238-239.
33. Forman JP, Giovannucci E., Holmes MD, et al. Plasma 25-Hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007 ; 49 (5). 1063-1069.
34. Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, Bleske BE Vitamin D and cardiovascular disease. Pharmacotherapy. 2009 ; 29 (6). 691-708.
35. Bubb KJ, Kett MM, Morley R., Wintour EM, Parkington HC, Tare M. Vitamin D insufficiency in utero and early life causes regional impairment in vascular reactivity and alters vascular compliance. J Vasc Res. 2008 ; 45 (suppl 1). 111.
36. Li YC, Kong J., Wei M., Chen ZF, Liu SQ, Cao LP 1,25-Dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotension system. J Clin Invest. 2002 ; 110 (2). 229-238.
37. Li YC Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003 ; 88 (2). 327-331.